back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-04-30 10:31 Tx date 2023-03-08 |
$KHRN
Khiron Life Sciences Corp. |
Cannainversiones S.A.S.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,705
+238,000 vol $0.0912 each |
12,296,429 | |
| Filed 2024-04-30 10:30 Tx date 2023-02-28 |
$KHRN
Khiron Life Sciences Corp. |
Cannainversiones S.A.S.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,200
+12,000 vol $0.10 each |
12,058,429 | |
| Filed 2022-09-06 17:10 Tx date 2022-09-06 |
$KHRN
Khiron Life Sciences Corp. |
Echeverry, Juan Carlos
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-120,000 vol |
0 | |
| Filed 2022-06-14 13:02 Tx date 2022-06-10 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+1,000,000 vol |
1,000,000 | |
| Filed 2022-06-14 13:01 Tx date 2022-06-10 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$150,000
+1,000,000 vol $0.15 each |
1,716,500 | |
| Filed 2022-06-14 12:58 Tx date 2022-06-10 |
$KHRN
Khiron Life Sciences Corp. |
Katterbach, Franziska Maximiliane Maria Therese
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+400,000 vol |
400,000 | |
| Filed 2022-06-14 12:58 Tx date 2019-10-01 |
$KHRN
Khiron Life Sciences Corp. |
Katterbach, Franziska Maximiliane Maria Therese
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-14 12:58 Tx date 2022-06-10 |
$KHRN
Khiron Life Sciences Corp. |
Katterbach, Franziska Maximiliane Maria Therese
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$60,000
+400,000 vol $0.15 each |
400,000 | |
| Filed 2022-06-14 12:57 Tx date 2019-10-01 |
$KHRN
Khiron Life Sciences Corp. |
Katterbach, Franziska Maximiliane Maria Therese
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-14 12:53 Tx date 2022-06-10 |
$KHRN
Khiron Life Sciences Corp. |
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+100,000 vol |
100,000 | |
| Filed 2022-06-14 12:53 Tx date 2018-05-24 |
$KHRN
Khiron Life Sciences Corp. |
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-14 12:53 Tx date 2022-06-10 |
$KHRN
Khiron Life Sciences Corp. |
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$15,000
+100,000 vol $0.15 each |
258,900 | |
| Filed 2022-06-14 12:46 Tx date 2022-06-10 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+400,000 vol |
400,000 | |
| Filed 2022-06-14 12:46 Tx date 2018-05-16 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-14 12:45 Tx date 2022-06-10 |
$KHRN
Khiron Life Sciences Corp. |
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$60,000
+400,000 vol $0.15 each |
1,305,000 | |
| Filed 2022-06-13 19:53 Tx date 2022-06-10 |
$KHRN
Khiron Life Sciences Corp. |
Kakumanu, Swapan
5 - Senior Officer of Issuer
Holder: Red to Black (Indirect Ownership)
|
Warrants
53 - Grant of warrants
|
$27,000
+135,000 vol $0.20 each |
135,000 | |
| Filed 2022-06-13 19:53 Tx date 2022-06-10 |
$KHRN
Khiron Life Sciences Corp. |
Kakumanu, Swapan
5 - Senior Officer of Issuer
Holder: Red to Black (Indirect Ownership)
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$20,250
+135,000 vol $0.15 each |
135,000 | |
| Filed 2022-06-13 19:52 Tx date 2021-10-01 |
$KHRN
Khiron Life Sciences Corp. |
Kakumanu, Swapan
5 - Senior Officer of Issuer
Holder: Red to Black (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-13 19:52 Tx date 2021-10-01 |
$KHRN
Khiron Life Sciences Corp. |
Kakumanu, Swapan
5 - Senior Officer of Issuer
Holder: Red to Black (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-13 19:18 Tx date 2022-06-10 |
$KHRN
Khiron Life Sciences Corp. |
Kakumanu, Swapan
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
$27,000
+135,000 vol $0.20 each |